Navigation Links
Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
Date:6/25/2009

PALO ALTO, Calif., June 25 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc., (NYSE: VAR) today announced it has acquired the assets of Houston-based IKOEmed and IKOEtech, privately-owned suppliers of software used in the planning of radiotherapy and radiosurgery treatments. The acquisition enables Varian to offer hospitals and clinics an additional software tool to automate and accelerate the most time-consuming portion of the treatment planning process. Varian is paying approximately $2.2 million plus an additional amount based on achievement of specified milestones to acquire the IKOE assets.

The software is designed to achieve greater than 50 percent reduction in the contouring portion of the radiotherapy treatment planning process, which typically takes anywhere from 30 minutes to 4 hours. It automates the contouring process by matching patient images with pre-contoured images from an expert database created by renowned radiation oncologists. This eliminates the need for clinicians to manually outline between 10 and 20 organs in each of anywhere from 100 to 200 images of a patient's disease site.

"This is another important step in our ongoing initiative to make cancer treatments better, faster, easier, and more cost effective," said Tim Guertin, president and CEO of Varian Medical Systems. "This new tool should save a lot of time in planning for complex cases, particularly in cancers of the head and neck and lymph systems." The IKOE software, which has FDA 510(k) clearance, complements Varian's existing segmentation tools currently used to automate planning for prostate, breast, and lung treatments.

Varian will sell the software initially in the U.S. as a standalone product that will work with most radiotherapy treatment planning software products in the industry. The company p
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Varian Medical Systems Exhibits Latest Technologies and Products Designed to Improve Speed and Precision of Radiotherapy at ESTRO 2007
3. Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
4. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
5. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
6. New SPE Cation Exchange Technology From Varian Simplifies Extraction of Basic Compounds
7. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
8. Varian, Inc. Reports First Quarter 2008 Results
9. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Nov. 5 Cepheid (Nasdaq:...be speaking at the following investor conferences,... , , Credit Suisse Healthcare Conf...November, 2009 at 10 a.m. Mountain Time, ...England, Tuesday, 1 December, 2009...
(Date:11/5/2009)...ov. 5 WaferGen Biosystem...loper of state-of-the-art genetic analysis systems...s joined the company,s Scientific Advisory Board. ...ercializing novel molecular diagnostics for cancer...lopment of computational biology systems for sever...
(Date:11/5/2009)... Drug safety specialty firm BioSoteria announced ...cs earned the Certified Professional in Learning a...merican Society for Training and Development (ASTD...ore than fifteen years of medical communications a...ble for the development of the company,s online ph...
(Date:11/4/2009)... This webinar, which will be presented on Novembe...nuous flow chemistry processing, will deal with th...g various meso and micro scale flow chemistry equi...ons has been recognized with several prestigious p... Tetrahedron Prize. , Col...
Breaking Biology Technology:Cepheid to Webcast Upcoming Financial Presentations 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...27 CV Therapeutics, Inc. (Nasdaq: CVTX ) today ... time in response to Astellas Pharma Inc.,s announ...isition, Inc., has commenced an unsolicited tender...rapeutics at a price of $16.00 per share in cash. ...sultation with its independent financial and legal...
...ed Life Sciences Holdings, Inc. (Nasdaq: ADLS ),...the U.S. Food and Drug Administration (FDA) that t...e (AIDAC) is tentatively scheduled to meet on June...n (NDA) for cethromycin, a new once-a-day oral ant...treatment of adults with mild-to-moderate communit...
...Boston Scientific Corporation (NYSE: BSX ) today...h quarter ended December 31, 2008. Subsequent to ... accrued for a patent litigation settlement and, a...ill impairment charge. In accordance with U.S. Ge...ts are required to be recorded in the fourth quart...
Other Biology Technology:CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer 2CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer 3Advanced Life Sciences Receives Notice of Planned Cethromycin Review by FDA Advisory Committee 2Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 2Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 3Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 4Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 5Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 6Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 7Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 8Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 9Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge 10
(Date:11/4/2009)...aboratory that deciphered the DNA codes, or genome...shark, has joined The Genome 10K Project, an inter...of DNA sequences on 10,000 species of animals for ...rently can not be achieved. , Participating in T...hed in the Nov. 5, 2009 issue of the Journal of H...
(Date:11/4/2009)...ss., Oct. 20 Aware, Inc.... technology and biometrics software, today reporte...eptember 30, 2009. ,, Michael Tzannes, Aware,...lier today, we announced an agreement to sell our ... new fabless semiconductor company being spun out ...
(Date:11/4/2009)...ILL Scientists at the University of North Carolin...sity of California, San Francisco have developed a...w target diseases for existing drugs. , The rese...ares how similar the structures of all known drugs...- known as ligands -- of disease targets within th...
Breaking Biology News(10 mins):Singapore scientists join international study of 10,000 vertebrates' genomes 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Study points to new uses, unexpected side effects of already existing drugs 2BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference 12576 1BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference 12576 2BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference 12576 3PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 1PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 2PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 3PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 4PAREXEL Enhances Study Start Up and Recruitment Capabilities With Appointment of Dr Lars Olof Eriksson Formerly With Merck 48561 5Unprecedented Scale Up of Voluntary Male Circumcision Begins in Swaziland and Zambia 48558 1Unprecedented Scale Up of Voluntary Male Circumcision Begins in Swaziland and Zambia 48558 2
...ime, that the release of the body,s own marijuana-...sia ?the body,s way of initially shielding pain af...ts at the University of Georgia and the University... drug therapies that will completely bypass the cu... In theory, the new research makes it possible to ...
...ses in America, and one that causes the most guilt...uman cell, reproduce in vast numbers, and linger f...rrent genital blisters to sores around the mouth. ...sceptibility to many nerve and brain disorders. , ... how the herpes simplex virus (HSV) manages to do ...
...s, circulating in a population at the same time, c...ne capable of infecting many more people, accordin...iology. This finding may help scientists make bett...ck during upcoming flu seasons and design more eff...fort to sequence the flu genome, Edward Holmes, Da...
Other Biology News:Scientists discover the body's marijuana-like compounds are crucial for stress-induced pain relief 2Scientists discover the body's marijuana-like compounds are crucial for stress-induced pain relief 3Achilles heel of the herpes virus possibly found 2Achilles heel of the herpes virus possibly found 3Achilles heel of the herpes virus possibly found 4Enlisting genomics to understand flu evolution 2
Conjugate Stabilizing Diluent HRP from Meridian Life Science, Inc.
...at fluorescent and radioisotopic image analysis an...t features four easy-to-access filters (filters of...Plates) for upgrading flexibility. In addition, th...nds of excitation laser beams. ,The system has a...
...nerates labeled cDNA for use in microarray hybridi...via a reverse transcription from mRNA into cDNA us...re are no unnatural modified nucleotides used in t... cDNA is then labeled in a one step 30 min. reacti...
... automated hybridization of microarrays on slides....d to offer researchers improved reproducibility, s...o perform a wide range of applications. Incubatio...ns of up to 99C. The possibility of 6 on-board rea...
Biology Products: